323
Participants
Start Date
February 28, 2010
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Cariprazine
Patients who meet eligibility criteria will be administered a once daily oral dose of cariprazine.
Placebo
Patients who meet eligibility criteria will be administered a once daily oral dose of placebo.
Forest Investigative Site 001, Flowood
Forest Investigative Site 008, Cleveland
Forest Investigative Site 009, Chicago
Forest Investigative Site 003, Creve Couer
Forest Investigative Site 006, Lake Charles
Forest Investigative Site 010, Oklahoma City
Forest Investigative Site 002, Houston
Forest Investigative Site 004, Long Beach
Forest Investigative Site 007, San Diego
Forest Investigative Site 005, Riverside
Forest Investigative Site 109, Kanpur
Forest Investigator Site 108, Varanasi
Forest Investigative Site 119, Lucknow
Forest Investigative Site 103, Ahmedabad
Forest Investigative Site 120, Ahmedabad
Forest Investigative Site 111, Pune
Forest Investigative Site 104, Pune
Forest Investigative Site 110, Nashik
Forest Investigative Site 101, Aurangabad
Forest Investigative Site 106, Vijayawada
Forest Investigative Site 112, Vizag
Forest Investigative Site 105, Bangalore
Forest Investigative Site 107, Bangalore
Forest Investigative Site 114, Mysore
Forest Investigative Site 118, Mangalore
Forest Investigative Site 113, Mangalore
Forest Investigative Site 115, Manipal
Forest Investigative Site 121, Chennai
Lead Sponsor
Collaborators (1)
Gedeon Richter Ltd.
INDUSTRY
Forest Laboratories
INDUSTRY